Functional and neurophysiological evidence of the efficacy of trophic pharmacotherapy using an adrenocorticotrophic hormone4-9 analog in experimental allergic encephalomyelitis, an animal model of multiple sclerosis

Neuroscience

Volumn 71, Issue 2, 1996, Pages 507-521

  Duckers, H J ^a   Van Dokkum, R P ^a   Verhaagen, J ^a   Lopes Da Silva, F H ^a   Gispen, W H ^a  

^a NONE

Author keywords

ACTH4 9; Analog; Chronic experimental allergic encephalomyelitis; Demyelinating disorder; Melanocortins; Neuroprotection; Rat

Indexed keywords

CORTICOTROPIN DERIVATIVE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEMYELINATION; ELECTROPHYSIOLOGY; EVOKED RESPONSE; FEMALE; MULTIPLE SCLEROSIS; NERVE REGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ADRENOCORTICOTROPIC HORMONE; AMINO ACID SEQUENCE; ANIMALS; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EVOKED POTENTIALS, SOMATOSENSORY; FEMALE; GAIT; MOLECULAR SEQUENCE DATA; MOTOR CORTEX; MULTIPLE SCLEROSIS; NEURAL PATHWAYS; NOCICEPTORS; PAIN MEASUREMENT; PEPTIDE FRAGMENTS; RATS; RATS, INBRED LEW; SOMATOSENSORY CORTEX; SPINAL CORD;

EID: 0030040737     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(95)00451-3     Document Type: Article

References (75)

1. Adan R. A. H., Cone R. D., Burbach J. P. H. and Gispen W. H. (1994) Differential effects of the melanocortin peptides on neural melanocortin receptors. Molec. Pharmac. 46, 1182-1190.
2. Allen I. and Brankin B. (1993) Pathogenesis of multiple sclerosis - The immune diathesis and the role of viruses. J. Neuropath. Expl Neurol. 52, 95-105.
3. Bär P. R., Schrama L. H. and Gispen W. H. (1990) Neurotrophic effects of ACTH/MSH-like peptides in the peripheral nervous system. In Neuropeptides, Basics and Perspectives (ed. De Wied D.), pp. 175-211. Elsevier Science Publishers, Amsterdam.
4. Baskin D. S. and Simpson R. K. (1987) Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat. Neurosurgery 20, 871-877.
5. Bernard C. C. A. and De Rosbo N. K. (1992) Multiple sclerosis: An autoimmune disease of multifactorial etiology. Curr. Opin. Immunol. 4, 760-765.
6. Bravenboer B., Kapelle A. C., Van Buren T., Erkelens D. W. and Gispen W. H. (1993) ACTH analog Org 2766 can ameliorate existing neuropathy in diabetic rats. Acta Diabetol. 30, 21-24.
7. Carew T. J. (1985) Posture and locomotion. In Principles of Neural Science (eds Kandel E. R. and Schwartz J. H.), pp. 478-486. Elsevier Science Publishers, Amsterdam.
8. Catania A. and Lipton J. M. (1993) α-Melanocyte stimulating hormone in the modulation of host reactions. Endocr. Rev. 14, 564-576.
9. Chiappa K. H. (1980) Pattern shift visual, brainstem auditory and short-latency somatosensory evoked potentials in multiple sclerosis. Neurology 30, 110-123.
10. Chiappa K. H. (1988) Use of evoked potentials for diagnosis of multiple sclerosis. Neurol. Clinics 6, 861-880.
11. Cowan J. M. A., Dick J. P. R., Day B. L., Rothwell J. C., Thompson P. D. and Marsden C. D. (1984) Abnormalities in central motor pathway conduction in multiple sclerosis. Lancet 2, 304-307.
12. Crang A. J., Franklin R. J. M., Blakemore W. F., Noble M., Barnett S. C., Groves A., Trotter J. and Schachner M. (1992) The differentiation of glial cell progenitor populations following transplantation into non-repairing central nervous system glial lesions in adult animals. J. Neuroimmunol. 40, 243-254.
13. De Koning P. and Gispen W. H. (1987) Org 2766 improves functional and electrophysiological aspects of regenerating sciatic nerve in the rat. Peptides 8, 415-422.
14. De Medinacelli L., Freed W. J. and Wyatt R. J. (1982) An index of the functional condition of the rat sciatic nerve based on measurements made from walking tracks. Expl Neurol. 77, 634-643.
15. De Wied D. and Jolles J. (1982) Neuropeptides derived from pro-opiocortin: behavioral, physiological and neurochemical effects. Physiol. Rev. 62, 976-1059.
16. Deguchi K., Takeuchi H., Miki H., Yamada A., Touge T., Terada S. and Nishioka M. (1992) Electrophysiological follow-up of acute and chronic experimental allergic encephalomyelitis in the Lewis rats. Eur. Arch. Psychiat. Clin. Neurosci. 242, 1-5.
17. Duckers H. J., van Dokkum R. P. E., Verhaagen J. and Gispen W. H. (1994) A neurotrophic ACTH(4-9) analog prevents the formation of central demyelinating lesions in CEAE and normalizes central conduction slowing. J. Neuroimmunol. 54, 164.
18. Duckers H. J., Verhaagen J., De Bruijn E. and Gispen W. H. (1994) Effective use of a neurotrophic ACTH(4-9) analog in the treatment of a peripheral demyelinating syndrome (EAN): an intervention study. Brain 117, 365-374.
19. Duckers H. J., Verhaagen J. and Gispen W. H. (1993) A neurotrophic analog of ACTH(4-9) protects against experimental allergic neuritis. Brain 116, 1059-1075.
20. Dyer J. K., Philipsen H. L. A., Tonnaer J. A. D. M. and Haynes L. W. (1993) An analysis of binding specificity of the α-MSH derivative ORG2766 in cultured rat Schwann cells. Ann. N. Y. Acad. Sci. 680, 496-498.
21. Eberle A. N. (1988) The Melanotropins: Chemistry, Physiology and Mechanisms of Action. Karger, Basel.
22. Evans T., McCarthy K. D. and Harden T. K. (1984) Regulation of cyclic AMP accumulation by peptide hormone receptors in immunocytochemically defined astroglial cells. J. Neurochem. 43, 131-138.
23. Fehlings M. G., Tator C. H., Dean Linden R. and Piper I. R. (1987) Motor evoked potentials recorded from normal and spinal cord-injured rats. Neurosurgery 20, 125-130.
24. Gerritsen van der Hoop R., Vecht C. J., Van der Burg M. E., Elderson A., Boogerd W., Heimans J. J., Vries E. P., Van Houwelingen J. C., Jennekens F. G. I., Gispen W. H. (1990) Prevention of cisplatin neurotoxicity with an ACTH(4-9) analog in patients with ovarian cancer. N. Engl. J. Med. 322, 89-94.
25. Gispen W. H. (1990) Therapeutic potential for melanocortins in peripheral nerve disease. Trends pharmac. Sci. 11, 221-222.
26. Groves A. K., Barnett S. C., Franklin R. J. M., Crang A. J., Mayer M., Blakemore W. F. and Noble M. (1993) Repair of demyelinating lesions by transplantation of purified O-2A progenitor cells. Nature 362, 453-455.
27. Hall R. D. and Lindholm E. P. (1974) Organisation of motor and somatosensory neocortex in the albino rat. Brain Res. 66, 23-38.
28. Happ M. P. and Heber-Katz E. (1988) Differences in the repertoire of the Lewis rat T cell response to self and non-self myelin basic proteins. J. exp. Med. 167, 502-513.
29. Hawkins C. P., MacKenzie F., Tofts P., du-Boulay E. P. and McDonald W. I. (1991) Patterns of blood-brain barrier breakdown in inflammatory demyelination. Brain 114, 801-810.
30. Hillert J. (1993) Immunoglobulin gamma constant gene region polymorphisms in multiple sclerosis. J. Neuroimmunol. 43, 9-14.
31. Hillert J. and Olerup O. (1993) Multiple sclerosis is associated with genes within or close to the HLA-DR-DQ subregion on a normal DR15, DQ6, Dw2 haplotype. Neurology 43, 163-168.
32. Juhler M. (1988) Pathophysiological aspects of acute experimental allergic encephalomyelitis. Acta. Neurol. Scand. 78, 3-21.
33. Kaji R., Tanaka R., Kawaguchi S., McMormick F. and Kameyama M. (1986) Origin of short-latency somatosensory evoked potentials to median nerve stimulation in the cat. Brain 109, 443-468.
34. Kakigi R., Kuroda Y., Neshige R., Endo C. and Shibasaki H. (1992) Physiological study of the spinothalamic tract conduction in multiple sclerosis. J. Neurol. Sci. 107, 205-209.
35. Kandler R. H., Jarratt J. A., Davies-Jones G. A. B., Gumpert E. J. W., Venables G. S., Sagar H. J. and Zeman A. (1991) The role of magnetic stimulation as a quantifier of motor disability in patients with multiple sclerosis. J. Neurol. Sci. 106, 31-34.
36. Kanje M., Magnusson S. and Svenningsson A. (1994) The ACTH(4-9) analog Org2766 stimulates proliferation of Schwann cells in the rat sciatic nerve. Neurosci. Res. Commun. 15, 135-140.
37. Keith A. B. (1978) Sex differences in Lewis rats in the incidence of recurrent experimental allergic encephalomyelitis. Nature 272, 824-825.
38. Kusunoki S., Yu R. K. and Kim J. H. (1988) Induction of experimental autoimmune encephalomyelitis in guinea pigs using myelin basic protein and myelin glycolipids. J. Neuroimmunol. 18, 303-314.
39. Lassmann H. (1983) Chronic relapsing experimental allergic encephalomyelitis: its value as an experimental model for multiple sclerosis. J. Neurol. 229, 207-220.
40. Lassmann H. (1983) Addendum: Materials and Methods - Models of chronic EAE. In Comparative Neuropathology of Chronic Experimental Allergic Encephalomyelitis and Multiple Sclerosis, pp. 111-121. Springer-Verlag, Berlin.
41. Lassmann H. (1983) Comparative Neuropathology of Chronic Experimental Allergic Encephalomyelitis and Multiple Sclerosis. Springer-Verlag, Berlin.
42. Lassmann H., Kitz K. and Wisniewski H. M. (1980) Structural variability of demyelinating lesions in different models of subacute and chronic experimental allergic encephalomyelitis. Acta neuropath., Berlin 51, 191-201.
43. Louis J. C., Magal E., Takayama S. and Varon S. (1993) CNTF protection by oligodendrocytes against natural and tumor necrosis factor-induced death. Science 259, 689-692.
44. Martin H. M. (1985) Receptor physiology and submodality coding in the somatic sensory system. In Principles of Neural Science (eds Kandel E. R. and Schwartz J. H.), pp. 287-300. Elsevier Science Publishers, Amsterdam.
45. McFarland H. F., Frank J. A., Albert P. S., Smith M. E., Martin R., Harris J. O., Patronas N., Maloni H. and McFarlin D. E. (1992) Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann. Neurol. 32, 758-766.
46. Merrill J. E. (1992) Proinflammatory and antiinflammatory cytokines in multiple sclerosis and central nervous system acquired immunodeficiency syndrome. J. Immunother. 12, 167-170.
47. Merton P. A. and Morton H. B. (1980) Stimulation of the cerebral cortex in the intact human subject. Nature 285, 227.
48. Michels R., Wessel K., Klöhn S. and Kömpf D. (1993) Long-latency reflexes, somatosensory evoked potentials and transcranial magnetic stimulation: Relation of the three methods in multiple sclerosis. Electroenceph. clin. Neurophysiol. 89, 235-241.
49. Mitchell G. (1993) Update on multiple sclerosis therapy. Medical Clinics of North America 77, 231-249.
50. Namer I. J., Steibel J., Poulet P., Armspach J. P., Mauss Y. and Chambron J. (1992) In vivo dynamic MR imaging in MBP-induced acute experimental allergic encephalomyelitis in Lewis rat. Magn. Reson. Med. 24, 325-334.
51. National Multiple Sclerosis Society (1993) Annual report, April 1993. Clinical trials in multiple sclerosis planned, in progress, recently completed 1-87.
52. Oksenberg J. R., Panzara M. A., Begovich A. B., Mitchell D., Erlich H. A., Murray R. S., Shimonkevitz R., Sherritt M., Rothbard J., Bernard C. C. A. and Steinman L. (1993) Selection for T-cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 362, 68-70.
53. Oksenberg J. R. and Steinman L. (1991) New approaches to the therapy of demyelinating disease. Curr. Opin. Neurobiol. 1, 436-440.
54. Onofri M., Gambi D., Bazzano S., Colamartino P., Fulgente T., Malatesta G. and Ferracci F. (1992) Evoked potentials (EPs) in experimental allergic encephalomyelitis: a study of EP modifications during the course of a controlled disease. Electromyogr. Clin. Neurophysiol. 32, 125-135.
55. Paty D. W., Willoughby E. W. and Whitaker J. N. (1992) Assessing the outcome of experimental therapies in multiple sclerosis patients. In Treatment of Multiple Sclerosis: Trial Design, Results and Future Perspectives (eds Rudick R. A. and Goodkin D. E.), pp. 47-90. Springer Verlag, London.
56. Pender M. P. (1986) Ascending impairment of nociception in rats with experimental allergic encephalomyelitis. J. Neurol. Sci. 75, 317-328.
57. Powers S. K., Bolger C. A. and Edwards M. S. B. (1982) Spinal cord pathways mediating somatosensory evoked potentials. J. Neurosurg. 57, 472-482.
58. Rappaport M., Leonard J. and Portillo S. R. (1992) Effect of anesthesia and stimulus intensity on posterior tibial nerve somatosensory evoked potentials. Clin. Electroenceph. 23, 24-30.
59. Richards D. B. and Lipton J. M. (1984) Effect of alpha-MSH 11-13 (lysine-proline-valine) on fever in the rabbit. Peptides 5, 815-817.
60. Rudick R. A. and Goodkin D. E. (1992) Treatment of Multiple Sclerosis: Trial Design, Results and Future Perspectives. pp. 1-307. Springer Verlag, London.
61. Ryder J., Zappulla R. and Nieves J. (1991) Motor evoked potentials elicited from pyramidal stimulation and recorded from the spinal cord in the rat. Neurosurgery 28, 550-558.
62. Sadovnick A. D. and Ebers G. C. (1993) Epidemiology of multiple sclerosis: A critical overview. Can. J. neurol. Sci. 20, 17-29.
63. Simpson R. K. and Baskin D. S. (1987) Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat: Correlation with neurological outcome and histological damage. Neurosurgery 20, 131-137.
64. Sporel-Ozakat R. E., Edwards P. M., Gerritsen van der Hoop R. and Gipsen W. H. (1990) An ACTH-(4-9) analog, Org 2766, improves recovery from acrylamide neuropathy in rats. Eur. J. Pharmac. 186, 181-187.
65. Strand F. L., Rose K. J., Zuccarelli L. A., Kume J., Alves S. E., Antonawich F. J. and Garrett L. Y. (1991) Neuropeptide hormones as neurotrophic factors. Physiol. Rev. 71, 1017-1046.
66. Svenningsson A., Hansson G. K., Andersen O., Andersson R., Patarroyo M. and Stemme S. (1993) Adhesion molecule expression on cerebrospinal fluid T lymphocytes: Evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls. Ann. Neurol. 34, 155-161.
67. Tienari P. J., Wikström J., Sajantila A., Palo J. and Peltonen L. (1992) Genetic susceptibility to multiple sclerosis linked to myelin basic protein gene. Lancet 340, 987-991.
68. Utz U., Biddison W. E., McFarland H. F., McFarlin D. E., Flerlage M. and Martin R. (1993) Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis. Nature 364, 243-247.
69. Van Calker D., Löffler F. and Hamprecht B. (1983) Corticotropin peptides and melanotropins elevate the level of adenosine 3′:5′-cyclic monophosphate in cultured murine brain cells. J. Neurochem. 40, 418-427.
70. Van der Zee C. E. E. M., Brakkee J. H. and Gipsen W. H. (1988) αMSH and Org2766 in peripheral nerve regeneration: different routes of delivery. Eur. J. Pharmac. 147, 351-357.
71. Wisniewski H. M. and Keith A. B. (1977) Chronic relapsing experimental allergic encephalomyelitis: an experimental model of multiple sclerosis. Ann. Neurol. 1, 144.
72. Woolfe G. and McDonald A. (1944) The evaluation of the analgesic action of pethidine hydrochloride (demerol). J. Pharmac. exp. Ther. 80, 300-307.
73. Yao D. L., Liu X., Hudson L. D. and Webster H. D. (1995) Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis. Proc. natn. Acad. Sci. U.S.A. 92, 6190-6194.
74. York D. H. (1987) Review of descending motor pathways involved with transcranial stimulation. Neurosurgery 20, 70-73.
75. Zohar M. and Salomon Y. (1992) Melanocortins stimulate proliferation and induce morphological changes in cultured rat astrocytes by distinct transducing mechanisms. Brain Res. 576, 49-58.